Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy

Abstract excerpt

Allogeneic hematopoietic stem cell transplantation has been well established for several decades as gene replacement therapy for patients with thalassemia major, and now offers very high rates of cure for patients who have access to this therapy. Outcomes have improved tremendously over the last decade, even in high-risk patients. The limited data available suggests that the long-term outcome is also excellent,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hemoglobinopathies and Related Disorders
• Share to Parvovirus B19 Infection Studies
• Share to Prenatal Screening and Diagnostics